Hydrostasis aims to be the standard of care in hydration monitoring. 75% of adults in the U.S. are chronically dehydrated, costing $20B annually and leading to chronic conditions such as diabetes, kidney disease, and dementia. Consumer device manufacturers are looking for better health insights; and clinicians need objective data and remote patient monitoring. Using patented sensor design and proprietary algorithms, the Hydrostasis solution is non-invasive, cross-platform, and device-agnostic. Hydrostasis is supported by SOSV, NIH, US Air Force, and has planned clinical validation studies at UCSD, NYU, and Azalee Care (Japan).